Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SBM Sistemi is a private Italian medical device company focused on ophthalmic diagnostic and treatment technologies, particularly for dry eye disease and ocular surface assessment. The company designs and manufactures electromedical ophthalmology devices and related software used by eye-care professionals, with products spanning tear film analysis, meibography, slit-lamp imaging, treatment systems, surgical planning tools, and veterinary ophthalmic diagnostics. Its portfolio appears to be fully commercial rather than a therapeutic drug pipeline, with notable products including IDRA, ACTIVA, OSA Vet, OS1000, DEM100, and Vision-AR-IOL Simulator. SBM Sistemi also supports a global distributor network and publishes clinical and educational content centered on dry eye and ocular surface evaluation. Overall, it is best characterized as a commercial ophthalmic medtech company rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SBM Sistemi.